Science News

COVID-19 Professional Resources
The AHA is working to ensure optimal care for patients with cardiovascular disease who contract coronavirus (COVID-19). Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with COVID-19. Here are some helpful resources for health systems, clinics, care providers, patients and the public.
HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19
03/16/2020 | Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with coronavirus disease 2019 (COVID-19).
Heart Disease and Stroke Statistics - 2020 Update
01/29/2020 | The age-adjusted death rate attributable to cardiovascular disease (CVD), based on 2017 data, is 219.4 per 100,000.
The AHA 2030 Impact Goal
01/29/2020 | Since the late 1990s, the AHA has committed to a singular impact goal to advance the AHA?s mission for the decade ahead.
Science News 2019 Scientific Sessions
11/16/2019 | Science News coverage of selected presentations and interviews from AHA's Scientific Sessions 2019. Nov. 16-18, 2019 in Philadelphia, PA.
CIRC AE | Live Twitter Chat | September 25
09/20/2019 | Circulation: Arrhythmia and Electrophysiology Live Twitter Chat
CIRCULATION Editor's Picks | August/September 2019
09/18/2019 | CIRCULATON Editor's Picks for August/September 2019
STROKE | Trending Topics | August 2019
09/13/2019 | Stroke Trending Topics for August 2019